Radiation-induced Desmoid Tumor Development in the Radiotherapy Field in a Child With Pineoblastoma: A Case Report

Although treatment-related secondary malignancies are rare, they are important problems after the treatment of childhood malignant diseases. Irradiation-induced sarcomas are the development of sarcoma different from the primary tumor after a latent period of ≥3 years or more in the radiotherapy field. Desmoid tumor is extremely rare as irradiation-induced tumor. A 7.5-year-old girl was referred to our hospital after a subtotal mass excision for a solid lesion with a cystic component located in the pineal gland. Pathologic examination revealed pineoblastoma. After surgery, craniospinal radiotherapy, and chemotherapy consisting of vincristine, cisplatin, and etoposide were performed. Painless swelling in the left parieto-occipital region ~75 months after the end of the treatment developed in the patient. A mass was detected in the intracranial but extra-axial region by radiologic imaging methods. Due to the total removal of the mass and the absence of a tumor in the surgical margins, she was followed up without additional treatment. The pathologic diagnosis was a desmoid tumor. She was followed up disease free for ~7 years after the primary tumor and ~7 months after the secondary tumor. Treatment-related desmoid tumor development after treatment for a central nervous system tumor in a child is extremely rare.

[1]  G. Falco,et al.  Radiation-induced sarcomas: A single referral cancer center experience and literature review , 2022, Frontiers in Oncology.

[2]  Gang Yin,et al.  Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities , 2022, Signal Transduction and Targeted Therapy.

[3]  L. Hazrati,et al.  WNT-activated embryonal tumors of the pineal region: ectopic medulloblastomas or a novel pineoblastoma subgroup? , 2020, Acta Neuropathologica.

[4]  Gautam Kumar,et al.  Radiotherapy and its impact on the nervous system of cancer survivors. , 2020, CNS & neurological disorders drug targets.

[5]  C. Scrideli,et al.  Molecular characterization of Wnt pathway and function of β-catenin overexpression in medulloblastoma cell lines , 2018, Cytotechnology.

[6]  Yi-Wei Chen,et al.  Irradiation-Induced Secondary Tumors following Pediatric Central Nervous System Tumors: Experiences of a Single Institute in Taiwan (1975-2013). , 2018, International journal of radiation oncology, biology, physics.

[7]  M. Perek-Polnik,et al.  Second brain tumors following central nervous system radiotherapy in childhood. , 2014, The British journal of radiology.

[8]  H. Schwartz,et al.  Morphologic and immunophenotypic analysis of desmoid-type fibromatosis after radiation therapy. , 2012, Human pathology.

[9]  A. Varan,et al.  Secondary Malignant Neoplasms After Childhood Cancer , 2011, Pediatric hematology and oncology.

[10]  Y. Komiya,et al.  Wnt signal transduction pathways , 2008, Organogenesis.

[11]  A. Varan,et al.  Second Neoplasms in Pediatric Patients Treated for Cancer: A Center's 30-year Experience , 2006, Journal of pediatric hematology/oncology.

[12]  A. Paulino,et al.  SECONDARY NEOPLASMS AFTER RADIOTHERAPY FOR A CHILDHOOD SOLID TUMOR , 2005, Pediatric hematology and oncology.

[13]  W Budach,et al.  Radiation induced CNS toxicity – molecular and cellular mechanisms , 2001, British Journal of Cancer.

[14]  M. Hudson,et al.  Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  H. Woodard,et al.  Sarcoma in irradiated bone. Report of eleven cases , 1948 .

[16]  T. Zhou,et al.  Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961. , 2013, Neuro-oncology.

[17]  P. Pizzo,et al.  Principles and Practice of Pediatric Oncology , 1989 .

[18]  R. Marcove,et al.  Radiation‐induced sarcoma of bone , 1971, Cancer.